Xtalks Announces its Life Science Webinar Calendar for November 2025

Date:










AI-Summary – News For Tomorrow

Xtalks is offering a series of free educational webinars in November covering various life science topics. These webinars are aimed at professionals in the life science, food, and medical device industries, as well as research institutions and healthcare centers. Key areas include cell and gene therapy, clinical trials, drug discovery and development, drug safety, healthcare, pharmaceutical regulation, and preclinical studies. Specific webinar topics range from optimizing clinical trial delivery with AI to streamlining cell line development and regulatory writing. Xtalks aims to keep professionals updated on industry trends, regulations, and key issues through insights from thought leaders.

News summary provided by Gemini AI.





Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, cell and gene therapy, clinical trials, commercialization & HEOR, drug discovery & development, drug safety, healthcare, patient recruitment & retention, pharma manufacturing & supply chain, pharmaceutical regulation and preclinical.

CELL AND GENE THERAPY
Nov 11 – Advancing Cell Therapy Development with Integrated Analytical and Process Strategies
Nov 13 – Where Will Your CGT Study Go? Solving the Site Capacity Challenge
Nov 20 – Ensuring compliance with animal-free raw materials in CGT

CLINICAL TRIALS
Nov 5 – Improving Translational Research and Clinical Trials with Digital Pathology
Nov 7 – The Evolution of Precision Medicine in Age-Related Neurological Diseases
Nov 10 – Improve Clinical Trial Delivery by Leveraging AI Forecasting Tools (Broadcast 1)
Nov 10 – Improve Clinical Trial Delivery by Leveraging AI Forecasting Tools (Broadcast 2)
Nov 12 – Engaging Underrepresented Voices to Improve Trial Access
Nov 13 – IVD Study Steps for Success: Safety and Quality of Global IVD Clinical Performance Studies
Nov 20 – Using Imaging in Clinical Trials to Improve Data and Decisions
Nov 21 – Enhancing Cardiometabolic Trials with Configurable eCOA and Digital Health Technologies

DRUG DISCOVERY & DEVELOPMENT
Nov 4 – Driving Success in Therapeutics with Recombinant Antibody Production
Nov 6 – Accelerating Drug Discovery from Virtual Screening to Lead Optimization
Nov 12 – Streamlining Cell Line Development for Faster Biologics Production
Nov 12 – Every Patient Matters: Bespoke Digital Endpoint Strategies for Rare Disease Drug Development
Nov 14 – Accelerating Radiopharmaceutical Therapy with Translational Tools
Nov 14 – Profiling Biology at Scale with DRUG-seq: From Mechanisms to Safety
Nov 19 – Crystallization Strategies for API Development and Scale-Up
Nov 20 – Clinical Signals and Strategic Shifts: Insights That Shape Oncology Drug Development
Nov 21 – Engineering Peptide Stability Through Azapeptide Synthesis and Applications
Nov 25 – Enhance Peptide Manufacturing Using Backbone N-Protecting Groups

DRUG SAFETY
Nov 11 – Safety & Regulatory Compliance Predictions For 2026: Unlock Safety & Regulatory Trends With IQVIA

HEALTHCARE
Nov 11 – Osmolality as a Key to Diagnosing Diabetes Insipidus

PHARMACEUTICAL REGULATION
Nov 3 – Regulatory Writing with Closed-Loop Gen-AI that Protects IP and Saves Time
Nov 14 – IRB & ICF Approval Simplified: 5 Key Considerations and Mistakes

PRECLINICAL
Nov 3 – Deconstructing OCD Through the Use of Multiple Operant Behavioral Tasks in Rodents

ABOUT  XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

SOURCE Xtalks

Source link

Share post:

Subscribe

Most Viewed

More like this
Related